Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Johnson and Johnson
McKesson
Colorcon
Moodys

Last Updated: January 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Supernus Pharmaceuticals, Inc v. Actavis Inc. (Fed. Cir. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Supernus Pharmaceuticals, Inc v. Actavis Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Supernus Pharmaceuticals, Inc v. Actavis Inc.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Supernus Pharmaceuticals, Inc v. Actavis Inc. (Fed. Cir. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-05-04 33 through dismissal (as it relates to U.S. Patent No. 8,617,600)., to terminate cross/consolidated appeal… 24 February 2016 16-1619 830 Patent Infringement (Fed. Question) External link to document
2016-05-09 36 WWWlnerrimll-websteJ.COln/dictionaryjnlatrix (accessed Dec. 4,409,212 A 10/1983 .\1ondadori …’898 Patent United States Patent No. 7,722,898131 patent United States Patent No. …Rudnic Patents. The Katzhendler Patent U.S. Patent No. 6,296,873 (the “Katzhendler Patent”) teaches… ‘89$ patent, the' 131 patent, and ‘600 patent, would infringe those patents; the '…infringement of U.S. Patent Nos. 7,722,898 (the “’898 patent”), 7,910,131 (the “’131 patent”), and 8,617,600 External link to document
2016-07-08 48 898 patent U.S. Patent No. 7,722,898131 patent U.S. Patent No. 7,910,131 Patents-in-…prior art, the Patent Examiner identified another patent [the ’452 patent] which disclosed… Actavis’s Tablets infringe the Patents-in-Suit and that the patents are not invalid. Actavis appeals…(Appx64 (citing Appx14176)). The ’452 patent cited by the patent examiner discloses PVP in the range …Oxcarbazepine The patent specifications and the prosecution history of the ’898 patent confirm that PVP External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Express Scripts
Merck
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.